INS and hyperlipidemia: Botolin S and McCabe LR found that BADGE treatment prevents diabetes-induced hyperlipidemia, effectively blocks diabetes type I-induced bone adiposity and reduces the induction of adipogenic gene expression in insulin-deficient diabetic BALB/c mice [14].